A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB

PHASE3CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 14, 2019

Study Completion Date

August 3, 2020

Conditions

Pulmonary Tuberculosis

Interventions

DRUG

Bedaquiline

100mg tablets

DRUG

PA-824

200mg tablets

DRUG

Linezolid

Scored 600mg tablets

Trial Locations (3)

Sizwe Tropical Disease Hospital, Sandringham

King DinuZulu Hospital Complex, Sydenham

Task Applied Science - Brooklyn Chest Hospital, Ysterplaat

All Listed Sponsors

lead

Global Alliance for TB Drug Development

OTHER

NCT02333799 - A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB | Biotech Hunter | Biotech Hunter